We are on a mission to improve protein production through disruptive technologies, specialising in animal iPS cells for cultivated meat.
Roslin Technologies has raised €14M across 2 funding rounds from 8 investors, most recently a Series A round in Nov 2022. Based in Edinburgh, UK; active in Agritech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-11-07 | Series A | €13M | Alchimia,Esco Lifesciences,Future Planet Capital,Kairos Capital Group,Novo Holdings,Nutreco | View deal → |
| 2021-11-04 | Grant | €1.2M | British Innovation Fund,UK Research and Innovation (UKRI) | View deal → |
